The Emory Pediatric Research Endocrine and Diabetes team works to provide resources to patients and families facing a wide range of endocrine-specific diseases in the form of research study drugs and investigational studies. From growth hormone treatments to diabetes prevention, the scope of our research spans the most critical areas within the pediatric endocrinology field. The ultimate goal of our efforts is to find the most innovative and effective treatment plans for those affected by these diseases while pursuing the possibility of eliminating and curing diabetes and other endocrine-related illnesses. 

***For information on participating in any study, please contact Karen Lindsley***

TrialNet Pathway to Prevention ​: Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is offered free to relatives of people with T1D to evaluate their personal risk of developing the disease. This unique screening can identify the early stages of T1D years before any symptoms appear. It also helps researchers learn more about how T1D develops and plan new studies exploring ways to prevent it. 

You qualify for free risk screening if you:

  • are between the ages of 1 and 45 and have a parent, brother/sister, or child with T1D
  • are between the ages of 1 and 20 and have an aunt/uncle, cousin, grandparent, niece/nephew, or half-brother/sister with T1D
  • have not been diagnosed with diabetes

Type 1 Diabetes Prevention - Abatacept : TrialNet is testing the drug Abatacept to see if it can delay or prevent progression of early stage T1D (stage 1 to stage 2) and ultimately prevent clinical diagnosis (stage 3). In earlier studies for people newly diagnosed with Type 1, Abatacept helped slow down disease progression. You must have have tested positive for certain autoantibodies during TrialNet screening to qualify.

Simponi (T1GER) : Combating β-cell Loss in Type 1 Diabetes using an Investigational Study Drug

Qualifying individuals must:

  • Be 6-21 years of age
  • Have received a Type 1 diabetes diagnosis within the last three months

PLATE : a clotting investigation in Type 1 Diabetes observating the clotting abilities of T1D patients and how living with diabetes alters the blood's ability to clot

Qualifying individuals must: 

  • Have received a Type 1 Diabetes diagnosis 2 or more years ago
  • Be between the ages of 6-18 years
  • Not currently be on glucocorticoid therapy


GUMP : an investigative study to better understand the pain-reducing aspects and efficacy of microneedles for the daily and routine administration of insulin in Type 1 Diabetes

Qualifying individuals would include those that: 

  • Received a Type 1 Diabetes diagnosis 2 or more years ago
  • Are between the ages of 6–18 years
  • Can demonstrate stable and controlled A1c levels


WEL-Kid : Type 2 Diabetes Research into the effects of Colesevalam on treatment and management

To participate, the patient must:

  • Not currently be using insulin to control their glucose
  • Have an A1c of 7%-10%
  • Be between the ages of 10-17

***For information on participating in any study, please contact Karen Lindsley***

OPKO : a comparative clinical research drug trial to see the efficacy of a new hormone replacement therapy in children with growth hormone deficiency compared to existing treatment options

Qualifying individuals would include that:

  • Are between the ages of 3-10 years (female) OR 3-11 years (male)
  • Currently have a diagnosis of Growth Hormone Deficiency (GHD) or Growth Hormone Insufficiency (GHI)
  • Are not currently be on a growth hormone therapy regimen

MASON : an investigative clinical research study into the development of diabetes in patients who have received major organ transplants. With a 1 in 10 chance of developing diabetes, post-transplant patients are monitored after their transplant and throughout their pediatric transplant treatment

Qualifying individuals would include those that:

  • Are between 1-21 years of age
  • Received or will be receiving their transplant(s) at a Children's Healthcare of Atlanta (CHOA) hospital
  • Have successfully received or will be receiving a heart, liver, or kidney transplant


Endocrine Autoimmunity : a clinical research study that uses blood donations to furtherunderstand the body's ability to use glucose, insulin, or other important body functions

  • All individuals qualify –there are no age, diagnosis, or gender exceptions. Healthy subjects can help out too!

Clinical Research Principal Investigators                     Clinical Research Coordinators and Support Staff

Dr. Andrew Muir                                                                Karen Lindsley, RN, MSN, CDE, CCRC, DNP(c)

Dr. Nina Jee-Young Ham                                                Margaret "Peggy" Jenkins, RN

Dr. Eric Felner                                                                     Lori Kwapil, CRC II

Dr. Leonidas Panagiatakopoulos (Dr. Leo)                 Wanda Sanchez, LPN, CRC II

                                                                                               Amber Antich, MA, CRC I

                                                                                               Kelsea Lozada, CNA, CRC I

Click below to submit a question or to get in touch with one of our team's coordinators - we're here to help!

Request an Appointment

Submit a Question